Since the discovery of O-GlcNAcylation of tau and its impact on tau phosphorylation, O-GlcNAcylation-related studies have rapidly increased in Alzheimer’s disease (AD) [3]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.